Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monette

Showing results (661-670 of 740) with videos related to

Pageof 74
Sort By:
Biorxiv : the Preprint Server for Biology|April 10, 2026
A Tissue Virus Microenvironment with Activated Stress Responses Underlies Durable SIV PersistenceThomas J Hope, Eliana U Crentsil, Muhammad S Arif, et al.
The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C TrialMartine Puts, Naser Alqurini, Fay Strohschein, et al.
Cell Reports|March 23, 2017
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell CarcinomaAmrita M Nargund, Can G Pham, Yiyu Dong, et al.
BMJ Open|May 13, 2019
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trialMartine T E Puts, Tina Hsu, Caroline Mariano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosisKaren Dybkær, Martin Bøgsted, Steffen Falgreen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Journal of Translational Medicine|July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Oncotarget|February 25, 2016
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible markerAna Batlle-López, Sonia González de Villambrosía, Mazorra Francisco, et al.
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Pageof 74

Showing results (661-670 of 740) with videos related to

Sort By:
Pageof 74
Biorxiv : the Preprint Server for Biology|April 10, 2026
A Tissue Virus Microenvironment with Activated Stress Responses Underlies Durable SIV PersistenceThomas J Hope, Eliana U Crentsil, Muhammad S Arif, et al.
The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2022
Impact of Geriatric Assessment and Management on Quality of Life, Unplanned Hospitalizations, Toxicity, and Survival for Older Adults With Cancer: The Randomized 5C TrialMartine Puts, Naser Alqurini, Fay Strohschein, et al.
Cell Reports|March 23, 2017
The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell CarcinomaAmrita M Nargund, Can G Pham, Yiyu Dong, et al.
BMJ Open|May 13, 2019
Clinical and Cost-effectiveness of a Comprehensive geriatric assessment and management for Canadian elders with Cancer-the 5C study: a study protocol for a randomised controlled phase III trialMartine T E Puts, Tina Hsu, Caroline Mariano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosisKaren Dybkær, Martin Bøgsted, Steffen Falgreen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
The Society for Immunotherapy of Cancer Perspective on Liquid Biopsy- and Radiomics-Based Technologies for Immuno-oncology Biomarker Discovery and ApplicationAnne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, et al.
Journal of Translational Medicine|July 20, 2023
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022)Paolo A Ascierto, Antonio Avallone, Carlo Bifulco, et al.
Oncotarget|February 25, 2016
Stratifying diffuse large B-cell lymphoma patients treated with chemoimmunotherapy: GCB/non-GCB by immunohistochemistry is still a robust and feasible markerAna Batlle-López, Sonia González de Villambrosía, Mazorra Francisco, et al.
Cancer Cell|August 15, 2018
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene MutationsStanley Chun-Wei Lee, Khrystyna North, Eunhee Kim, et al.
Pageof 74